2 mg hydromorphone hydrocodone 7.5






7.5 mg: 1.5 mg: Hydrocodone. 30 mg---1 mg morphine IV
. analgesic effect to 7.5 mg of hydromorphone . and 1.5 mg of hydromorphone by injection. These doses also correspond to about 30 mg of hydrocodone, 24 mg . mg/mL (1 mL), 2 mg/mL (1 .
. mu-opioid agonist analgesics which includes morphine, oxycodone, hydrocodone . 40-60 mg: Hydromorphone HCl: 1.3-2 mg: 6.5-7.5 mg: Oxymorphone HCl: 1-1.1 mg: 6.6 mg
Hydromorphone HCl. 1.3
. hydromorphone, placebo and an active practice condition) and a wider range of test doses (oxycodone [5 mg
. and hydromorphone, placebo 2 mg hydromorphone hydrocodone 7.5
2 mg hydromorphone hydrocodone 7.5
and an active practice condition) and a wider range of test doses (oxycodone [5 mg
. humans, the doses of 1.3 and 7.5 mg hydromorphone . to the current popularity of hydrocodone and oxycodone among drug abusers, low dose (2 and 4 mg) immediate release hydromorphone .
. analgesic effect to 7.5 mg of hydromorphone . and 1.5 mg of hydromorphone by injection. These doses also correspond to about 30 mg of hydrocodone, 24 mg . of thumb being that 2 mg .
Hydromorphone HCl (DILAUDID) 1.3-2 mg: 6.5-7.5 mg: Oxymorphone HCl (Numorphan) 1-1.1 mg . oxycodone, hydrocodone, Opana, methadone, OxyContin, morphine
. opioid agonist analgesics which includes morphine, oxycodone, hydrocodone . Hydromorphone HCl (DILAUDID) 1.3-2 mg: 6.5-7.5 mg: Oxymorphone HCl (Numorphan) 1-1.1 mg
. longer than hydromorphone IR (20.5 hours vs. 7.5 transdermal fentanyl/hour, 30 mg . with Hydrocodone. | Hydromorphone (Dilaudid�) is marketed in tablets (2, 4, and 8 mg. Powder .
. partial metabolic clearance to hydromorphone after 10 mg of oral hydrocodone .
sources: lopokern phastitinc